Prednisolone Sodium Phosphate 1% / Moxifloxacin HCl 0.5% / Bromfenac 0.075% Ophthalmic Solution
Quantity: 8 mL
Price: Call 833.540.3500 or login to the Practitioner Portal for pricing.
Sig: Beginning ____ days before surgery, place 1 drop in affected eye _____ times daily and taper as directed.
Sterile compounded ophthalmic preparation available by prescription. The FDA does not review any compounded medication for safety or efficacy.
What is Pred-Moxi-Brom?
Prednisolone Sodium Phosphate 1% / Moxifloxacin HCl 0.5% / Bromfenac 0.075% Ophthalmic Solution is a compounded sterile eye drop that ophthalmologists may explore to address postoperative inflammation, infection risk, and ocular discomfort in a single formulation.
This combination brings together a corticosteroid, antibiotic, and NSAID—three classes commonly used in ophthalmic care—into one drop to support simplified regimens and patient adherence.
Because commercially available products are typically prescribed separately, compounded combination formulations may be considered when a prescriber prefers a consolidated approach for an individual patient.
What is the Mechanism of Action?
Each active ingredient contributes to a different aspect of ocular management:
Prednisolone Sodium Phosphate
- Reduces inflammation by suppressing inflammatory mediators
- Helps control postoperative swelling and immune response
Moxifloxacin HCl
- Inhibits bacterial DNA replication
- Provides broad-spectrum antibacterial coverage against common ocular pathogens
Bromfenac
- Inhibits cyclooxygenase (COX) enzymes
- Reduces prostaglandin production associated with pain and inflammation
Together, these mechanisms target inflammation, microbial risk, and discomfort, which are commonly managed simultaneously in ophthalmic care.
Clinical Scenarios Where Ophthalmologists Explore Pred-Moxi-Brom Eye Drops
Ophthalmologists may consider this compounded combination in scenarios such as:
- Postoperative care following cataract surgery
- Procedures involving intraocular manipulation where inflammation control is needed
- Situations where adherence is a concern, and simplifying multiple drops into one may be beneficial
- Patients managing multiple ophthalmic medications, where regimen consolidation may improve compliance
- Prescriber preference for combination therapy tailored to an individual patient
Use is determined by the treating ophthalmologist based on the procedure, patient history, and clinical goals.
Why Ophthalmologists Choose Massey Drugs
- Sterile compounding laboratory experienced in ophthalmic preparations
- Preservative-free formulations tailored for ocular use
- Direct pharmacist access for clinical questions
- Fast turnaround with patient shipment typically within 24–48 hours
- Experience working with corneal specialists and surgical practices
- NABP Accredited Compounding Pharmacy
States We Serve
Massey Drugs is a sterile ophthalmic compounding pharmacy licensed to ship ophthalmic solutions to patients in: Alabama, Tennessee, Mississippi, Louisiana, Georgia, Florida, North Carolina, South Carolina, Kentucky, Illinois, Indiana, Ohio, Pennsylvania, New York, Connecticut, and Texas.
How to Prescribe Pred-Moxi-Brom Eye Drops
Download Rx Blank from the Practitioner Portal and send to Massey Drugs:
FAX: 800.637.2601
Phone: 833.540.3500
OR
e-Scribe: NPI#: 1295756245 | NCPCP#: 0127553
Massey Drugs | Cloverdale Road
Upon receipt of prescription, Massey Drugs contacts the patient to confirm shipping address and credit card payment.
Medication ships to patient in 24-48 hours
once processed.
Massey Drugs provides competitively priced compounded ophthalmic eye drops with transparent, prescriber-accessible pricing. All compound pricing can be viewed in our Practitioner Portal so costs can be communicated to patients before prescribing.
Speak with a Pharmacist
If you have questions about ophthalmic compounding, formulation options, or whether this therapy may be appropriate for a specific clinical scenario, our pharmacists are available to consult. Call 833-540-3500 or contact us.
Frequentley Asked Questions
What is this combination eye drop used for?
This compounded ophthalmic solution is typically explored for postoperative eye care, where inflammation, infection risk, and discomfort are managed together.
Why combine prednisolone, moxifloxacin, and bromfenac into one drop?
Each medication addresses a different aspect of care. Combining them into a single drop may simplify dosing and improve patient adherence compared to using multiple separate prescriptions.
Is this a replacement for standard postoperative eye drops?
Treatment decisions are made by the prescribing ophthalmologist. This compounded formulation may be considered when a provider prefers a combined approach for a specific patient.
Is this formulation commercially available?
No. This exact combination is not widely available as a commercial ophthalmic product and is prepared by a compounding pharmacy when prescribed.
Who is a candidate for this compounded eye drop?
Patients undergoing ophthalmic procedures or managing postoperative care may be considered, based on provider evaluation and treatment goals.
Additional Ophthalmic Compounding Capabilities
We compound additional sterile ophthalmic therapies used for:
- Post-operative Care
- Emergency & Infection Management
- Emergency & Corneal Scarring Support
- Glaucoma Compounding
- Myopia Management
Explore our full range of ophthalmic compounding capabilities.